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ABSTRACT
Objective: There are multiple post-operative pain protocols for patients who undergo total knee arthroplasty (TKA). Post-operative analgesia with 
opioids or epidural analgesia has its side effect. We compared the duration of hospital stay, pain score, and range of motion of a control group who had 
no local infiltration with a group who had local infiltration analgesia following TKA.
Methods: Randomization was done in 60 patients who underwent TKA in two groups, one who did not receive and the other who received a 
multimodal cocktail periarticular injection containing 30 ml of 0.5% bupivacaine, 1 ml of 30 mg ketorolac, 1 ml of 1 in 1000 adrenaline, 2 ml of 80 
mg gentamycin, 5 ml of 750 mg cefuroxime, and rest 0.9% of normal saline. Visual analog score (VAS) for pain at rest was recorded and assessed 
preoperatively and postoperatively at 2, 6, 12, 24, 36 h, 2, 3, and 7 days and during an activity at 24 h, 36 h, 2, 3, and 7 days.
Results: The patient who had received the local injection used very few analgesics over the first 24 h of surgery. Moreover, patients, where local 
infiltration was used, showed lower VAS for pain (at rest and during activity). They also showed higher VAS for patients’ satisfaction.
Conclusion: Due to the reduced post-operative pain with periarticular injection analgesia, it was observed that the pain and duration of hospital stay 
were significantly reduced.
Keywords: Total knee arthroplasty, Local infiltration, Epidural analgesia, Multimodal cocktail periarticular injection.
INTRODUCTION
Total knee arthroplasty (TKA) is regarded as the most successful 
operative treatment for advanced osteoarthritis of the knee joint 
improving quality of life [1]. Following TKA, severe post-operative pain 
in the first 24 h results in prolonged hospital stay [2]. Thus, adequate 
pain relief after TKA is one of the topmost priorities in the immediate 
post-operative period resulting in improvement of patient satisfaction, 
early rehabilitation and reducing hospital stay duration, and decreasing 
the risk of post-operative complications such as deep vein thrombosis 
and pneumonia [3-5].
At present, there are various methods of post-operative analgesia 
available, which include patient-controlled analgesia (PCA), continuous 
epidural pump, peripheral nerve block, local intra-articular analgesia, 
and continuous intra-articular infusion of analgesics, but each having 
its adverse effects [6-8]. The side effects of spinal/epidural anesthesia 
are intraoperative hypotension, post-operative headaches, neurogenic 
bladder, risk of infection of the spine, respiratory depression, and an 
increase in the total dosage of deep venous thrombosis prophylactic 
medicines [9]. Regional anesthesia (femoral nerve block/sciatic 
nerve block) is associated with infection, hematoma formation, risk 
of neurovascular damage, and narcotics which can lead to nausea, 
vomiting, respiratory depression, somnolence, urinary retention, and 
decreased gut motility [10-13]. Continuous intra-articular infusion of 
analgesics may cause considerable joint effusion and may be a source 
of infection. Preferably, a multimodal approach of analgesia protocol 
should be adopted, blocking pain at its origin to prevent complications 
and side effects while maintaining maximum muscle control for post-
operative mobilization and physiotherapy. The use of multimodal 
cocktail periarticular injection (MCPI) has been reported to be effective 
in controlling pain, fewer adverse effects, cost-effective, and easy to 
use and requires no special training when compared to femoral nerve 
blocks or epidural anesthesia. Multiple recent studies have documented 
the efficacy of local infiltration of analgesics for TKA [14,15]. 
In our study, we used a combination of a local analgesic solution 
consisting of a nonsteroidal anti-inflammatory drug (ketorolac), a long-
acting local anesthetic (bupivacaine), and antibiotics (cefuroxime and 
gentamycin), with adrenaline, to determine the overall effect of this 
MCPI on immediate post-operative pain, joint range of motion (ROM), 
and length of hospital stay after primary TKA.
METHODS
A prospective, randomized, and double-blinded controlled trial was 
conducted between June 2018 and November 2019, during which 
84 consecutive patients with tri-compartmental osteoarthritis 
were enrolled in the study. After our study had been approved by 
the Institutional Ethics Committee and patients who had signed an 
informed consent form were considered eligible for unilateral TKA. 
The patients were included between 50 and 75 years of age (mean 
age: 65.8 years) and the range of BMI was 18.5–42.1 kg/m2 (mean: 
30.2 kg/m2). Patients were excluded if they weighed more than 
100 kg, which had a major psychological illness, dependence on 
alcohol, narcotics, or chronic users of opioids, history of allergy to 
morphine or any of the drugs being injected, previous history of stroke, 
uncontrolled angina with prolonged QT intervals or arrhythmia, 
renal impairment, abnormal coagulopathy, abnormal liver function, 
rheumatoid arthritis, diabetes mellitus, uncontrolled hypertension, 
neuromuscular deficit, acute or chronic knee infection, previous knee 
surgery, previous patellectomy, knee with severe varus and valgus 
deformity (> than 20°), fixed flexion deformity (>15°), and ROM 
(<90°) to avoid erroneous assessment of the ROM postoperatively. 
© 2020 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Twenty-four patients did not meet the required criteria; hence, they 
were excluded from the study.
Study design (randomization and blinding)
Participants were randomized into two treatment groups: 
(A) Intervention group and (B) control group. SPSS Version 20.0 
software (SPSS, Chicago, Illinois) was used to create a randomization 
table by a study coordinator (an independent hospital pharmacist), 
who prepared and provided the medication for periarticular injection 
in identical disposable syringes tagged with code numbers. He did 
not have any involvement in surgery or patient care. A simple random 
table was used for generating the cards which had a random number 
sequence and was in sealed envelopes. Odd/even numbers were used 
by the study coordinator for the allocation of the enrolled patients 
to Group A/B which was random and double-blinded. The surgeon, 
nurses, and pharmacists who collected post-operative patients’ data 
were blinded to treatment group allocation. The release of the blinding 
codes was done subsequently in the data analysis stage.
Spinal anesthesia was given by an anesthetist to all the patients 
with morphine (0.3 mg) and 3 mL of 0.5% heavy bupivacaine. No 
epidural anesthesia was used in our patients. All patients were given 
preoperatively pregabalin 150 mg, intravenous infusion of magnesium 
at the rate of 50 mg/kg over 30 min (max 3 g) then 15 mg/kg/h 
till the end of the surgery, and 2 g IV of tranexamic acid as a bolus. 
Cefuroxime (1.5 g) was given for prophylaxis 30 min before starting 
the operation. Midazolam (1–2 mg) was given to anxious patients 
during the operation. A Foleys catheter and tourniquet were used in 
all our patients. A single surgeon performed all the operations. For all 
the surgeries, the approach was through an anterior midline incision 
and standard medial parapatellar arthrotomy. Cemented posterior 
stabilized total knee prostheses were used in both groups (Zimmer 
Nexgen: USA). The patella was resurfaced in all cases. Insertion of 
a non-suction drain was done before the closure of the wound and 
removal was done after 24 h. Removal of the Foleys catheter was done 
on post-operative day 1 along with the starting of isometric exercises 
and ROM. The ambulation of the patients was done with a walker as 
per their tolerance.
Intervention
Group A (local infiltration group)
A cocktail of 60 ml was prepared under aseptic measure using 30 ml of 
0.5% bupivacaine, 1 ml of cefuroxime, and rest 0.9% of normal saline 
(Table 1).
After lavage of the surgical site, equal doses of the mixture were injected 
into each of the following eight sites (Fig. 1):
(1) The posterior capsule (Fig. 2), (2) the medial capsular incision 
(Fig. 3), (3) the lateral capsular incision (Fig. 4), (4) the subcutaneous 
tissue along both edges of the incision (Fig. 5), (5) the medial collateral 
ligament, (6) the lateral collateral ligament, (7) the retinacular tissues, 
and (8) the quadriceps mechanism.
Excessive infiltration was avoided in the area around the common 
peroneal nerve. Infiltration was done through an 18 gauges needle and 
was infiltrated before the tourniquet is released. The posterior capsule 
was injected after the bone cut was done and the remainder of capsular 
infiltration was done after the final component was implanted and 
while bone cement was polymerizing.
Group B (control group)
Infiltration of an equal amount of 0.9% normal saline solution was done 
in the control group as in the intervention group in the same areas and 
similar techniques.
Both the groups received as follows:
1. Injection amoxicillin (1.2 g) I.V. twice daily
2. Injection cefuroxime (1.5 g) I.V. twice daily
3. Injection paracetamol (1 g) I.V. thrice daily
4. Injection diclofenac (75 mg) I.V. twice daily
5. Topical cold therapy was given thrice daily until the discharge of the 
patient
6.	 For	the	first	72	h,	a	sequential	compression	device	was	used
7. Low molecular weight heparin (0.3 ml–0.4 ml) was given 
subcutaneously daily until discharge for the prevention of deep vein 
thrombosis.
Outcome measures
The follow-up of the patients was done postoperatively and assessed 
daily during the hospital stay. The recording of the scores was done in 
a double-blind fashion to make the reviewer uninformed of the side of 
infiltration as also the patient.
Table 1: Composition of multimodal cocktail injection
S. No. Drug Dose (conc.) Volume
1. Bupivacaine 0.5% 30 ml
2. Ketorolac 30 mg 1 ml
3. Adrenaline 1:1000 1 ml
4. Gentamycin 80 mg 2 ml
5. Cefuroxime 750 mg 5 ml
6. Normal saline 0.9% 21 ml
Total 60 ml
Fig. 1: The eight regions of the knee (marked in red) having 
increased pain receptors
Fig. 2: Multimodal cocktail periarticular injection being 
infiltrated in the posterior capsule
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Fig. 3: Multimodal cocktail periarticular injection being 
infiltrated in the medial capsule
Fig. 4: Multimodal cocktail periarticular injection being 
infiltrated in the lateral capsule
Fig. 5: Multimodal cocktail periarticular injection being 
infiltrated in the medial aspect of subcutaneous tissue
Primary outcome measure
Pain relief
The collection of data was done by the investigators who were familiar 
with the assessment methods and those who were not a participant in 
the study. Visual analog score (VAS) was used to assess the severity of 
pre-operative pain both at rest and during activity. Assessment of post-
operative pain was done through VAS at 2, 6, 12, 24, and 36 h and on 
2nd, 3rd, and 7th days at rest and 24 h, 36 h, 2nd, 3rd, and 7th days during 
activity. Pre-operative and post-operative ROM was measured on 1st, 
2nd, 3rd, and 7th days.
The total amount of paracetamol and diclofenac consumed was 
recorded for post-operative day 3. The monitoring of patients was 
done for the adverse effects of bupivacaine, for example, cardiac and 
central nervous system toxicity. The presence of nausea and vomiting, 
pruritus, or urinary retention, and somnolence were also determined. 
The complications which occurred during the trial were recorded, 
especially surgical site infections, wound condition, and opioid-related 
complications.
Secondary outcome measures
Duration of hospital stay
The calculation was done from the day of admission and discharge of 
the patient. Patients were discharged when they fulfilled the following 
discharge criteria:
•	 Mild pain (VAS< 3) controlled by oral analgesics
•	 Independent use of the toilets
•	 Weight-bearing with walker
•	 No surgical complications.
ROM
The ROM was assessed by the physiotherapist, who measured the post-
operative knee flexion with the help of goniometer on 1st, 2nd, 3rd, and 7th 
days. Follow-up of all the patients was done on 1, 3, 6, and 12 months 
postoperatively. Pre-operative and post-operative knee scores were 
recorded at 1, 3, 6, and 12 months.
Statistical analysis
The mean±SD for continuous variables and the frequency and 
percentage for categorical variables was calculated. Processing of the 
data was done through SPSS statistical software (version 20.0) (SPSS 
Inc., USA). Univariate analysis was performed by Chi-square or Fisher’s 
exact test to compare the distribution between categorical data. The 
Mann–Whitney U-test was done to correlate the non-parametric 
significant	 data	 between	 two	 independent	 samples.	 p≤0.05	 was	
considered to be statistically significant.
RESULTS
In our study, we found that the pain score was significantly lower 
1st post-operative day in the locally infiltrated group. There was a 
significant pain score difference on the 2nd and 3rd post-operative days. 
The decrease in the average maximum pain score in the intervention 
group was significant as compared to the control group (Figs. 6 and 7). 
There was no significant difference in the wound complication rate 
between these groups. There was a significant difference in the ROM 
until post-operative day 7 and in the mean duration of hospital stay 
(Figs. 8 and 9).
DISCUSSION
Post-operative pain following TKA is a major problem. The pain 
is usually due to trauma to soft tissues or bone or hyperperfusion 
after tourniquet release. Adequate pain relief is essential for early 
rehabilitation postoperatively. Surgical trauma causes peripheral and 
central sensitization due to a rise in the excitability of spinal neurons. 
This causes hypersensitivity and decreases the pain threshold at the 
operative site. Adrenaline helps in keeping the infiltrated drugs locally 
and prevents drug toxicity through its vasoconstriction properties. 
Bupivacaine blocks afferent peripheral nociceptive activity [4,14]. 
Ketorolac blocks inflammatory cytokines and reduces peripheral 
sensitization of neurons. Tranexamic acid reduces post-operative 
bleeding, and pregabalin reduces post-operative pain by binding to α2δ 
unit of presynaptic Ca channel, reducing the release of substance P, 5HT, 
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noradrenaline, dopamine, and by attenuating postsynaptic excitability. 
Magnesium reduces post-operative pain by its properties of N-methyl-
d-aspartate (NMDA) receptor antagonist and calcium channel blocker. 






























Fig. 6: Pain at rest as measured by a visual analog score in patients who received multimodal cocktail periarticular analgesia (30 patients 

































Fig. 7: Pain during activity as measured by a visual analog score in patients who received multimodal cocktail periarticular analgesia 
(30 patients in the injected group) as compared to (30 patients in the control group). Pre-op: Pre-operative, POD: Post-operative day
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peripheral nociceptive stimulation and abolishes hypersensitivity by its 
antagonism of the NMDA receptor [16,17].
Busch et al. studied the efficacy of local perioperative injection with 
ropivacaine, ketorolac, epinephrine, epimorphine, and normal saline in 
TKA patients which resulted in a lower pain score and less consumption 
of analgesics at 12 h after the operation as compared to a control 
group [14]. Badner et al., in their study of the effects of intraoperative 
intra-articular bupivacaine-epinephrine injection in TKA patients, 
showed a decrease in the consumption of post-operative analgesics 
with an increase in ROM at discharge in the infiltrated patients, but 
no significant relief of pain was noted on the addition of morphine 
to a bupivacaine injection [18]. Vendittoli et al. showed a decrease in 























Fig. 9: Duration of hospital stay in patients who received multimodal periarticular analgesia (30 patients in the injected group) as 

























Fig. 8: Range of motion (knee flexion) in patients who received multimodal periarticular analgesia (30 patients in the injected group) as 
compared to (30 patients in the control group). Pre-op: Pre-operative
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underwent intraoperative periarticular infiltration with adrenaline, 
ketorolac, ropivacaine, and ropivacaine injection (150 mg) on day 1 
post-surgery [19]. Parvataneni et al. reported that local perioperative 
infiltration with a cocktail of epinephrine, morphine sulfate, 0.5% 
bupivacaine, cefuroxime, methylprednisolone acetate, and 0.9% normal 
saline in joint replacement surgeries resulted in increased satisfaction 
scores, decreased pain score at 72 h, and reduced hospital stay [20]. 
Pang et al. showed the inclusion of triamcinolone acetonide to the 
periarticular injection after TKA resulted in immediate and short-term 
benefits in pain relief and rehabilitation. There was no increase in the 
risk of infection in this study [21]. Lamplot et al. reported a decrease in 
the duration of hospital stay in the infiltrated group in comparison to 
the PCA group [22]. Lombardi et al. studied the efficacy of soft tissue 
and intra-articular bupivacaine, morphine, and epinephrine injection 
in patients who underwent primary TKAs and reported a reduction in 
the need for rescue doses of narcotic medicines as well as significant 
pain relief, but nothing significant improvement was found in terms 
of length of hospital stay and ROM [23]. Mullaji et al. studied the 
effects of an intra-articular analgesic cocktail containing bupivacaine, 
methylprednisolone, fentanyl, and cefuroxime in patients undergoing 
bilateral computer-assisted TKA showing significant improvement in 
pain scores and active flexion up to 4 weeks with quadriceps recovery 
up to 2 weeks [24].
In our study, the mean VAS in the injected group at rest was 38.25±14.78 
and during activity was 41.62±11.59 suggesting significant pain reliefs 
as compared to the mean VAS of 44.62±17.62 at rest and 51.8±11.56 
during activity in the control group. The mean ROM in our study was 
82.14±16.41 in the injected group, whereas 72.29±23.17 in the control 
group. Hence, faster rehabilitation was seen in the injected group. 
There was a substantial reduction in the duration of hospital stay in the 
injected group in comparison to the control group in our study.
CONCLUSION
Intraoperative periarticular analgesic injection significantly reduces 
post-operative pain and reduces the requirement of post-operative 
analgesics with no apparent risk, following TKA. We observed a lesser 
length of hospital stay in local analgesia injected group than those who 
were not injected. The local analgesia infiltrated groups were able to 
bear weight much earlier than the non-infiltrated group.
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